Articles > Business magazines > Specialty and Local Interest magazines > BT Catalyst articles > April-June 2002 > Monday, April 1

Article: Merix's personalized cancer vaccines could change the face of cancer therapy. (Company Profile).

Article from:
BT Catalyst
Article date:
April 1, 2002
Copyright

Personalized cancer vaccines may sound like the stuff of science fiction novels, but Merix Bioscience Inc. of Durham has the technology and most of the financial backing to turn a seemingly futuristic idea into real therapies.

Quietly formed in 1997 to develop and commercialize novel vaccine technology from Duke University in Durham, Merix made a big splash last year when it raised $39.5 million from various U.S. and international investors, including Durham-based Aurora Funds and Intersouth Partners.

Mark Weedon joined the company as president and CEO in 2001 and led the financing deal. A former top executive for the Canadian arm of former Glaxo and ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: MERIX Bioscience Completes $39.5 Million Private ...
Business Wire;  September 10, 2001 ;     700+ words ... ... will be used to advance clinical trials for a cancer vaccine and to expand the powerful MERIX platform for immunostimulation ... the potential of the MERIX immunology platform ... personalized cancer vaccine clinical trials at Duke University Medical ... Executive Officer of MERIX ...

Article: MERIX RAISES $39.5M PRIVATELY TO ACCELERATE VACCINE ...
BIOWORLD Today;  September 13, 2001 ;     700+ words ... ... money is expected to allow Merix to acquire additional capabilities ... said the current facilities Merix occupies and that are being ... feet to be fitting out for the clinical trials that we expect to begin in ... and Senmed Medical Ventures. Merix also appointed three new members ...

Article: Merix Bioscience announces cancer vaccines agreement.
Cancer Weekly;  April 13, 2004 ;     700+ words ... ... antitumor immune response. Merix retains co-exclusive ... uncharacterized antigens. Merix's platform technology has been validated in several clinical trials at Duke, including the ongoing trial which combines Merix's antigen delivery technology ...

Article: MERIX Bioscience Establishes European Subsidiary.
Business Wire;  October 11, 2001 ;     700+ words ... ... Over the next 2 years MERIX plans to invest more ... pre-clinical and clinical trials focusing on MERIX's proprietary RNA ... based dendritic cell clinical trials in the world at the ... and complement, the MERIX clinical trial programs ...

Article: Merix Bioscience Announces Agreement with Geron ...
Business Wire;  March 11, 2004 ;     700+ words ... ... uncharacterized antigens. Merix's platform technology ... validated in several clinical trials at Duke, including ... trial which combines Merix's antigen delivery ... moving toward initial clinical trials in both." About Merix Merix Bioscience ...

Article: Merix Raises A Record $39.5M.
BT Catalyst;  October 1, 2001 ;     700+ words ... ... Erlangen, Germany. Merix will construct a manufacturing ... future preclinical and clinical trials focusing on Merix's proprietary RNA ... based adult cell clinical trials in the world. His ... contribute to the Merix clinical trial programs ...

Article: MERIX Bioscience Appoints World's Leading Dendritic Cell ...
Business Wire;  October 11, 2001 ;     700+ words ... ... MERIX Bioscience. The MERIX platform is based on ... conducting research and/or clinical trials at their respective ... previously licensed by MERIX from Duke University ... pre-clinical and clinical trials was raised in a $39 ...

Article: MERIX Bioscience Appoints Clint G. Dederick, Jr. as Chief ...
Business Wire;  September 16, 2002 ;     700+ words ... ... invaluable contributors to MERIX's continued success ... involvement that helped build MERIX as a well funded early stage ... Company to deliver successful clinical trials and to establish a truly international ... Munich/Germany and member of MERIX's Board of Directors ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives